Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy

American Journal of Kidney Diseases

Volumn 40, Issue 3, 2002, Pages 489-494

  Satko, Scott G ^a   Langefeld, Carl D ^a   Daeihagh, Pirouz ^a   Bowden, Donald W ^a   Rich, Stephen S ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans (AAs); Chronic kidney disease (CKD); Familial aggregation; Prevention; Proteinuria; Type 2 diabetic nephropathy (DN)

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; SIBLING;

EID: 0036723888     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.34888     Document Type: Article

References (27)

1. The epidemic of end-stage renal disease in the United States: A public health perspective on ESRD prevention
2. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. Effect of lipid reduction on the progression of renal disease: A meta-analysis
5. Changing patterns of end-stage renal disease due to hypertension
6. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
7. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
8. Clinical practice recommendations 1997
9. Comparison of diabetes care provided by an endocrinology clinic and a primary-care clinic
10. The Oregon Health Plan: Predictors of office-based diabetic quality of care
11. Change over four years in testing for proteinuria in Medicare beneficiaries with diabetes mellitus (DM) by primary care physicians
12. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines
13. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus
14. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease
15. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy
16. Familial clustering of end-stage renal disease in blacks with lupus nephritis
17. A family-based strategy to identify genes for diabetic nephropathy
18. Segregation analysis of urinary albumin excretion in families with type 2 diabetes
19. Segregation analysis of diabetic nephropathy in Pima Indians
20. Prevalence of nephropathy in black patients with type 2 diabetes mellitus
21. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus
22. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
23. Microalbuminuria as a predictor of clinical diabetic nephropathy
24. Screening of high risk populations identifies a high prevalence of individuals with abnormal renal function: The NKF Kidney Early Evaluation Program
25. Targeted screenings identify persons at risk for kidney disease